{
  "guideline_questions": [
    {
      "category": "Patient selection and risk factors",
      "questions": [
        "How does age influence complication rates after post-mastectomy breast reconstruction, and is age alone a reason to avoid reconstruction?",
        "How does increasing BMI or obesity influence complications in implant-based versus autologous reconstruction?",
        "How do smoking and diabetes affect complication risk, and are they contraindications or modifiable risk factors?",
        "What is the impact of prior radiotherapy on complications and patient-reported outcomes by reconstruction type?"
      ]
    },
    {
      "category": "Timing and radiotherapy pathways",
      "questions": [
        "Among patients without radiotherapy, how do immediate and delayed reconstruction compare in overall and major complications?",
        "Among patients without radiotherapy, how do immediate and delayed reconstruction compare in patient-reported outcomes?",
        "In patients receiving radiotherapy, how do implant outcomes differ by timing, including contracture and implant loss?",
        "What evidence supports waiting at least six months after radiotherapy before delayed reconstruction?"
      ]
    },
    {
      "category": "Nipple-sparing mastectomy",
      "questions": [
        "How do oncologic outcomes of nipple-sparing mastectomy compare to skin-sparing mastectomy?",
        "What patient and tumor selection criteria are used for nipple-sparing mastectomy?",
        "What evidence supports tumor-to-nipple distance thresholds and which cutoffs have been studied?",
        "How accurate is frozen section of the nipple base for assessing nippleâ€“areolar complex involvement?"
      ]
    },
    {
      "category": "Implant plane selection",
      "questions": [
        "How do prepectoral and subpectoral implant reconstructions compare in overall complications?",
        "What evidence quantifies animation deformity and pain in subpectoral reconstruction?",
        "What outcomes are reported after conversion from subpectoral to prepectoral implants?"
      ]
    },
    {
      "category": "ADM and synthetic mesh",
      "questions": [
        "How does acellular dermal matrix use compare to no ADM for infection, seroma, implant loss, and reoperation?",
        "Which ADM or synthetic mesh products are evaluated and how comparable are the datasets?",
        "How do studies address confounding between ADM use and implant plane selection?"
      ]
    },
    {
      "category": "Fat grafting and patient-reported outcomes",
      "questions": [
        "What evidence supports the oncologic safety of autologous fat grafting after breast cancer?",
        "How should BREAST-Q results be interpreted using minimal important difference thresholds?"
      ]
    }
  ]
}
